06 April 2021 : Original article
Intensified Endoscopic Evaluation for Biliary Complications After Orthotopic Liver Transplantation
Tim R. Glowka1ABCDEF*, Caroline Karlstetter1BCF, Tobias J. Weismüller2BCD, Tim O. Vilz1CD, Christian P. Strassburg2CD, Jörg C. Kalff1CD, Steffen Manekeller1ACDEFDOI: 10.12659/AOT.928907
Ann Transplant 2021; 26:e928907
Table 1 Demographics.
| No biliary complications | Biliary complications | P | |
|---|---|---|---|
| n=59 | n=43 | ||
| Age (a) | 54 (45–63) | 58 (51–63) | 0.18 |
| Gender | 0.38 | ||
| Male | 38 (64%) | 21 (49%) | |
| Female | 21 (36%) | 19 (51%) | |
| BMI | 25.30±4.04 | 25.99±5.05 | 0.45 |
| Cause of cirrhosis* | |||
| Alcohol | 17 (29%) | 9 (21%) | 0.37 |
| Viral hepatitis | 22 (37%) | 6 (14%) | |
| Primary sclerosing cholangitis | 10 (17%) | 4 (9%) | 0.27 |
| Other | 15 (25%) | 25 (58%) | |
| Hepatocellular carcinoma | 17 (29%) | 10 (23%) | 0.53 |
| labMELD | 20 (9–32) | 28 (12–36) | 0.17 |
| High urgent transplant | 8 (14%) | 5 (12%) | 0.77 |
| Child-Turcotte-Pugh | |||
| A | 17 (29%) | 10 (23%) | 0.53 |
| B | 20 (34%) | 12 (28%) | 0.52 |
| C | 22 (37%) | 21 (49%) | 0.24 |
| Blood group | |||
| 0 | 25 (42%) | 12 (28%) | 0.13 |
| A | 18 (31%) | 25 (58%) | |
| Previous abdominal surgery | 22 (37%) | 25 (58%) | |
| Redo transplantation | 5 (8%) | 6 (14%) | 0.52 |
| TIPS prior to surgery | 10 (17%) | 8 (19%) | 0.83 |
| Pre-existing conditions | |||
| Cardiac | 9 (15%) | 11 (26%) | 0.2 |
| Pulmonary | 9 (15%) | 10 (23%) | 0.31 |
| Renal | 22 (37%) | 22 (51%) | 0.16 |
| Diabetes | 11 (19%) | 13 (30%) | 0.17 |
| CMV donor positive | 19 (32%) | 18 (42%) | 0.35 |
| CMV recipient positive | 27 (46%) | 17 (40%) | 0.48 |
| Data are expressed as number (%), mean±standard deviation or median (interquartile range). TIPS – transjugular intrahepatic portosystemic shunt. * Multiple responses possible. | |||